# Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy

> **NCT07212595** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Stuart Goldstein, MD** · enrollment: 30 (estimated)

## Conditions studied

- Acute Kidney Injury
- Mechanical Ventilation

## Interventions

- **DRUG:** Amino Acid infusion
- **DRUG:** Lactated ringers solution

## Key facts

- **NCT ID:** NCT07212595
- **Lead sponsor:** Stuart Goldstein, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-11
- **Final completion:** 2027-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07212595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07212595, "Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07212595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*